Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MBOT declined for three days, in 284 of 328 cases, the price declined further within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for MBOT entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 21 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Moving Average Convergence Divergence (MACD) for MBOT just turned positive on October 22, 2026. Looking at past instances where MBOT's MACD turned positive, the stock continued to rise in 34 of 48 cases over the following month. The odds of a continued upward trend are 71%.
MBOT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.918) is normal, around the industry mean (2.874). P/E Ratio (-3.768) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (263.158) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. MBOT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBOT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
SSII saw its Momentum Indicator move below the 0 level on September 23, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned negative. In 71 of the 77 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for SSII turned negative on October 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 31 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SSII declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for SSII entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SSII's RSI Oscillator exited the oversold zone, 23 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where SSII advanced for three days, in 61 of 91 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
SSII may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.846) is normal, around the industry mean (2.923). P/E Ratio (0.000) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (12.887) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. SSII’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 94 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SSII’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
MBOT | SSII | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 62 | 72 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 29 Undervalued | 58 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 94 | |
SMR RATING 1..100 | 97 | 96 | |
PRICE GROWTH RATING 1..100 | 91 | 86 | |
P/E GROWTH RATING 1..100 | 9 | 100 | |
SEASONALITY SCORE 1..100 | 90 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MBOT's Valuation (29) in the Biotechnology industry is in the same range as SSII (58) in the null industry. This means that MBOT’s stock grew similarly to SSII’s over the last 12 months.
SSII's Profit vs Risk Rating (94) in the null industry is in the same range as MBOT (100) in the Biotechnology industry. This means that SSII’s stock grew similarly to MBOT’s over the last 12 months.
SSII's SMR Rating (96) in the null industry is in the same range as MBOT (97) in the Biotechnology industry. This means that SSII’s stock grew similarly to MBOT’s over the last 12 months.
SSII's Price Growth Rating (86) in the null industry is in the same range as MBOT (91) in the Biotechnology industry. This means that SSII’s stock grew similarly to MBOT’s over the last 12 months.
MBOT's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for SSII (100) in the null industry. This means that MBOT’s stock grew significantly faster than SSII’s over the last 12 months.
| MBOT | SSII | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | 2 days ago 77% |
| Stochastic ODDS (%) | N/A | 2 days ago 78% |
| Momentum ODDS (%) | N/A | 2 days ago 90% |
| MACD ODDS (%) | 1 day ago 71% | 2 days ago 82% |
| TrendWeek ODDS (%) | 1 day ago 84% | 2 days ago 89% |
| TrendMonth ODDS (%) | 1 day ago 84% | 2 days ago 87% |
| Advances ODDS (%) | N/A | about 1 month ago 67% |
| Declines ODDS (%) | 2 days ago 87% | 4 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 80% | 2 days ago 76% |
| Aroon ODDS (%) | 1 day ago 86% | 2 days ago 89% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MBOT’s FA Score shows that 2 FA rating(s) are green while SSII’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MBOT’s TA Score shows that 3 TA indicator(s) are bullish while SSII’s TA Score has 4 bullish TA indicator(s).
MBOT (@Medical/Nursing Services) experienced а -0.85% price change this week, while SSII (@Medical/Nursing Services) price change was -10.74% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.50%. For the same industry, the average monthly price growth was -10.64%, and the average quarterly price growth was -10.25%.
MBOT is expected to report earnings on Nov 11, 2026.
SSII is expected to report earnings on Oct 27, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor tells us that SSII and VNRX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SSII and VNRX's prices will move in lockstep.
| Ticker / NAME | Correlation To SSII | 1D Price Change % | ||
|---|---|---|---|---|
| SSII | 100% | -5.12% | ||
| VNRX - SSII | 26% Poorly correlated | -3.93% | ||
| MBOT - SSII | 23% Poorly correlated | -0.78% | ||
| SINT - SSII | 22% Poorly correlated | N/A | ||
| QSI - SSII | 21% Poorly correlated | +6.03% | ||
| LUCY - SSII | 16% Poorly correlated | +4.44% | ||
More | ||||